| Profile | GDS1873 / 44040_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 285.105 | 63 |
| GSM40788 | control - Rep 2 | 238.83 | 59 |
| GSM40789 | control - Rep 3 | 278.256 | 63 |
| GSM40775 | androgen treated - Rep 1 | 216.508 | 56 |
| GSM40776 | androgen treated - Rep 2 | 245.765 | 60 |
| GSM40777 | androgen treated - Rep 3 | 242.479 | 59 |
| GSM40790 | estrogen treated - Rep 1 | 231.719 | 58 |
| GSM40791 | estrogen treated - Rep 2 | 239.892 | 59 |
| GSM40792 | estrogen treated - Rep 3 | 280.796 | 63 |
| GSM40784 | A + tamoxifen - Rep 1 | 240.06 | 59 |
| GSM40785 | A + tamoxifen - Rep 2 | 228.123 | 57 |
| GSM40786 | A + tamoxifen - Rep 3 | 239.952 | 59 |
| GSM40778 | A + anastrozole - Rep 1 | 229.249 | 58 |
| GSM40779 | A + anastrozole - Rep 2 | 263.136 | 61 |
| GSM40780 | A + anastrozole - Rep 3 | 298.687 | 65 |
| GSM40781 | A + letrozole - Rep 1 | 266.704 | 62 |
| GSM40782 | A + letrozole - Rep 2 | 244.364 | 59 |
| GSM40783 | A + letrozole - Rep 3 | 255.737 | 61 |